Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome
Authors
Keywords
-
Journal
RENAL FAILURE
Volume 44, Issue 1, Pages 923-932
Publisher
Informa UK Limited
Online
2022-05-27
DOI
10.1080/0886022x.2022.2079525
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Esculetin alleviates murine lupus nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway
- (2022) Ying Zhang et al. JOURNAL OF ETHNOPHARMACOLOGY
- The roles of NLRP3 inflammasome-mediated signaling pathways in hyperuricemic nephropathy
- (2021) Li Wen et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Innate immunity in diabetic kidney disease
- (2020) Sydney C. W. Tang et al. Nature Reviews Nephrology
- Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
- (2020) Sandra Rayego-Mateos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The tubular hypothesis of nephron filtration and diabetic kidney disease
- (2020) Volker Vallon et al. Nature Reviews Nephrology
- The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis
- (2020) Amani Abraheem Alsadiq Alyaseer et al. Frontiers in Immunology
- Trimetazidine Inhibits Renal Tubular Epithelial Cells to Mesenchymal Transition in Diabetic Rats via Upregulation of Sirt1
- (2020) Yong Yang et al. Frontiers in Pharmacology
- Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches
- (2020) Chetan Ram et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent evidence in the etiology and treatment for diabetic kidney disease
- (2020) Kenichi Shikata Journal of Diabetes Investigation
- New Insights Into the Role and Mechanism of Partial Epithelial-Mesenchymal Transition in Kidney Fibrosis
- (2020) Lili Sheng et al. Frontiers in Physiology
- Novel Immunomodulatory Cytokine Regulates Inflammation, Diabetes, and Obesity to Protect From Diabetic Nephropathy
- (2019) Vikram Sabapathy et al. Frontiers in Pharmacology
- Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the PI 3K/Akt pathway in diabetic rat
- (2019) Wei‐Jian Ni et al. Journal of Diabetes Investigation
- The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
- (2019) Yang Gyun Kim et al. Cells
- Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?
- (2018) Paul Perco et al. KIDNEY INTERNATIONAL
- IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice
- (2018) Rui Wu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Tubulointerstitial Biomarkers for Diabetic Nephropathy
- (2018) Bancha Satirapoj Journal of Diabetes Research
- Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway
- (2018) Shanshan Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy
- (2018) Kehong Chen et al. FASEB JOURNAL
- New therapeutic agents in diabetic nephropathy
- (2017) Yaeni Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
- (2016) Maryam Afkarian et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
- (2016) Yuan-ye Qiu et al. PHARMACOLOGICAL RESEARCH
- Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction?
- (2015) Ivonne Loeffler et al. Cells
- Renal Tubulointerstitial Fibrosis in OVE26 Type 1 Diabetic Mice
- (2008) David W. Powell et al. NEPHRON EXPERIMENTAL NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now